Journal for ImmunoTherapy of Cancer (Nov 2023)
1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells
Abstract
No abstracts available.